-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Tissue Factor Pathway Inhibitor As Biomarker in Cancer Associated Thrombosis

Scientific Workshop on Interplay Between Coagulation and Malignancy
Program: Scientific Workshops
Session: Tissue Factor(TF) and Tissue Factor Pathway Inhibitor(TFPI) in Cancer Associated Thrombosis
Friday, December 6, 2024, 2:05 PM-3:05 PM

Florian Moik, MD, PhD

Department of Internal Medicine, Division of Oncology, Medical University of Graz, Graz, Austria

Disclosures: Moik: Servier: Honoraria; Bristol-Myers Squibb: Honoraria; Johnson & Johnson: Consultancy; MSD: Honoraria; Merck: Honoraria.

See more of: Tissue Factor(TF) and Tissue Factor Pathway Inhibitor(TFPI) in Cancer Associated Thrombosis
See more of: Scientific Workshop on Interplay Between Coagulation and Malignancy
See more of: Scientific Workshops
<< Previous Presentation | Next Presentation >>